Navigation Links
New Chief Executive Reports Q1 Results and Sets out Strategy for Growth
Date:5/2/2013

151.2 14%

Non GAAP cost of product sales as a percentage of product sales decreased slightly in Q1 2013, due to improved margins in the ADHD portfolio which were only partially offset by lower margins on other products.

Research and Development ("R&D")

% of % of product product Q1 2013 sales Q1 2012 sales $M $M R&D (US GAAP) 224.2 20% 220.3 20% Payments in respect of in-licensed and acquired products - (23.0) Depreciation (4.6) (6.4) R&D (Non GAAP) 219.6 20% 190.9 17%

Non GAAP R&D increased by $28.7 million, or 15%, due to our increased investment in a number of targeted R&D programs including non-ADHD programs for LDX, and spend on SPD602 for Iron Overload and SRM003 for Acute Vascular Repair, acquired since Q1 2012.

US GAAP R&D increased by $3.9 million, or 2%, a lower rate of increase than on a Non GAAP basis as Q1 2012 included payments in respect of acquired and in-licensed products, not repeated in Q1 2013.

Selling, General and Administrative ("SG&A")

% of % of product product 2013 sales 2012 sales $M $M SG&A (US GAAP) 438.7 39% 500.0 45% Intangible asset amortization (45.9) (45.6) Legal and litigation costs(1) (4.2) - Depreciation (16.7) (13.6) SG&A (Non GAAP) 371.9 33% 440.8 40%

  1. In Q2 2012 Shire amended its Non GAAP policy to exclude costs related to the settlement of litigation, government investigations and other disputes, together with related external legal costs. Non GAAP SG&A in Q1 2012 has not been restated as the amounts incurred in that period were not significant.

Non GAAP SG&A decreased by $68.9 million, or 16%, partly due to the benefit of actions taken during last year, in addition to careful management of our cost base. The rate of decline in SG&A in Q1 2013 was accentuated by the high level of SG&A in Q1 2012 relative to the level of spend in subsequent qua
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

Related medicine technology :

1. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
2. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
3. Nephros Appoints John C. Houghton as President and Chief Executive Officer
4. Chesapeake Urologys Dr. Brad Lerner, Chief of Urology at Union Memorial Hospital, Honored with Governors Citation for Outstanding Service
5. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
6. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
7. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
8. Neal K. Long appointed as Chief Executive Officer at Cardiac Science
9. Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
10. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
11. Wake Forest Baptist Names President of Piedmont Triad Research Park and Chief Innovation Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 UBM Medica ... a leading online community to help oncologists and other ... available regarding the use of targeted therapies and immunotherapies, ... research and treatment.  Every September, ... way to raise awareness about blood cancers—helping to increase ...
(Date:9/19/2014)... DALLAS , September 19, 2014 ... Market by Equipment Type (Benchtop, Mobile, Industrial, & ... Others), Technology (Tray-style, Manifold, & Rotary) & Geography ... by MarketsandMarkets, defines and segments the lyophilization market ... regions with analyses and projections of the market ...
(Date:9/19/2014)... 2014  Lpath, Inc. (NASDAQ: LPTN ... announced today that it has entered into definitive ... stock and 3,605,042 unregistered warrants in a registered ... registered share of common stock and one unregistered ... stock will be $3.475.  The warrants have an ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
... and UBM Canon,s Medical Device Media Group will co-host a ... component selection in an advanced medical system. Dubbed, S ... be led by industry expert Robert Hult. As the ... has nearly 40 years experience in the connector industry, with ...
... 2011 Herborium Group, Inc., (Pinksheets: HBRM) www.herborium.com ... following update today. Dr. Agnes Olszewski, Chairmen ... exciting times for our Company. Firstly, we have continued ... maintaining Herborium, Current Information Status– the highest ...
Cached Medicine Technology:Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar 2Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar 3Herborium Group Shareholders Update 2Herborium Group Shareholders Update 3
(Date:9/20/2014)... 6 Minutes to Skinny , a fat loss ... is showing men and women of all ages how they ... using simple 6-minute exercises and easy-to-follow lifestyle tips daily, has ... , “When it comes to losing body fat, unfortunately ... all people,” reports Michaels. “Metabolism plays a big role in ...
(Date:9/20/2014)... 2014 Increases in household, construction ... waste treatment volumes. However, government regulations and higher ... landfill. According to IBISWorld industry analyst Alen Allday, ... aimed at reducing the volume of waste generated, ... recovered.” Still, a large proportion of waste generated ...
(Date:9/20/2014)... September 20, 2014 As testosterone ... in federal court, Bernstein Liebhard LLP notes that ... (FDA) have voted overwhelmingly to recommend that prescription ... be subjected to further study in order to ... published on September 18th by Bloomberg.com, the panel ...
(Date:9/20/2014)... 2014 (HealthDay News) -- As flu season approaches, the ... to get a flu shot and a checkup, according ... care doctor can vaccinate people against the flu, and ... have. Retail stores may provide flu shots for their ... Dr. Jorge Parada, medical director of infection prevention and ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 As ... http://www.injurybeacon.com/power-morcellator/ ) in gynecological surgeries continue to ... insurer has announced plans to end coverage for ... its website last month, Harrisburg, Pennsylvania-based Capital BlueCross ... 1, 2014. The insurer said its decision was ...
Breaking Medicine News(10 mins):Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:Get a Flu Shot During Checkup, Doctor Says 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3
... -- Revenue of $99.7 million, up 23.6% year-over-year or up 30.9% ... of $11.3 million or $0.32 per diluted share, compared to a ... Highlights: -- Revenue of $423.4 million, up 45.5% ... -- Net income of $24.0 million or $0.68 per diluted ...
... Johnson & Johnson/Basilea,s or Forest/Novexel,s Drug Could Be ... Report from AMR and Decision ResourcesMALVERN, Pa. and ... (AMR) and Decision Resources find that activity against ... attributes influencing surveyed physicians, antibiotic selection for the ...
... students react better to stress, are less fatigued, have more ,integrated, brains , , , , , ... , , , ... , , , ... VIDEO: , Fred Travis, lead author and director of MUM,s Center for Brain, ,Consciousness and ...
... The Board of the Walter and Eliza Hall Institute ... the Institute,s next Director.Announcing Professor Hilton,s appointment as Director-Designate, ... that the directorship of WEHI is among the most ... world. This fact had demanded the most rigorous global ...
... ON, Feb. 24 /PRNewswire-FirstCall/ - Nuvo Research Inc. (TSX: ... research and development of drug products delivered to and ... delivery technologies, today announced that Nuvo,s INSIGHT(TM) platform, developed ... fqubed, Inc., has been selected as one of four ...
... Hard-Pressed Business SectorKIRKLAND, Wash., Feb. 24 For people ... healthcare front. They can often insure themselves for less, ... can use company dollars for a tax-deductible plan for ... of the Board of LTC Financial Partners LLC (LTCFP), ...
Cached Medicine News:Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 2Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 3Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 4Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 5Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 6Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 7Health News:Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results 8Health News:Activity Against Drug-Resistant Pathogens is One of the Leading Attributes Influencing Physicians' Antibiotic Selection for the Treatment of Inpatient Community-Acquired Pneumonia 2Health News:Activity Against Drug-Resistant Pathogens is One of the Leading Attributes Influencing Physicians' Antibiotic Selection for the Treatment of Inpatient Community-Acquired Pneumonia 3Health News:Transcendental Meditation buffers students against college stress: Study 2Health News:Transcendental Meditation buffers students against college stress: Study 3Health News:Transcendental Meditation buffers students against college stress: Study 4Health News:Transcendental Meditation buffers students against college stress: Study 5Health News:The Walter and Eliza Hall Institute Announces the Next Director 2Health News:The Walter and Eliza Hall Institute Announces the Next Director 3Health News:The Walter and Eliza Hall Institute Announces the Next Director 4Health News:Nuvo's High Throughput Experimentation Platform Selected as 2009 Edison Award Finalist 2Health News:Nuvo's High Throughput Experimentation Platform Selected as 2009 Edison Award Finalist 3Health News:Long Term Care Insurance for Business Owners & Executives: Tax Benefits Often Overlooked 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: